Brouwer W B, Koopmanschap M A, Rutten F F
Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands.
Health Econ. 1997 Sep-Oct;6(5):511-4. doi: 10.1002/(sici)1099-1050(199709)6:5<511::aid-hec297>3.0.co;2-k.
In this response we concentrate on what Weinstein et al. call the 'major disagreement' between the Erasmus group and the US Panel, which concerns the measurement of productivity losses during illness. We consider the consequences for the individual, for the employer and for the rest of society and argue that when following the Panel's propositions for measuring these consequences, major theoretical and practical difficulties are encountered.
在本回应中，我们聚焦于温斯坦等人所称的伊拉斯谟小组与美国专家组之间的“主要分歧”，该分歧涉及患病期间生产力损失的衡量问题。我们考量了对个人、雇主及社会其他群体的影响，并指出，若遵循专家组关于衡量这些影响的主张，将会遇到重大的理论和实际困难。
